全球医疗用品和设备市场 - 2024-2031

2023年，全球医疗用品和设备市场达到1,431亿美元，预计2031年将达到1,885.8亿美元，2024-2031年预测期间复合年增长率为3.6%。

医疗用品和设备在医院和诊所用于手术等医疗目的。这些用品使医疗保健专业人员能够评估患者的医疗需求。医疗用品和设备包括储存和运输、耐用医疗设备、诊断和电子医疗设备。

医疗用品和设备市场是由慢性病患病率不断上升、对新型治疗方案的需求不断增加、认识不断提高、患者对更好治疗的需求不断增长以及治疗方案的进步等因素推动的。由于北美地区各大公司的强大影响力，预计该地区将占据最大的市场份额。

市场动态：

驱动程式和限制

慢性病和传染病的盛行率不断上升

慢性病盛行率的不断上升预计将成为全球医疗用品和设备市场成长的重要因素。预计该市场将受到癌症、糖尿病和心血管疾病等慢性病患者数量不断增加的推动。例如，根据美国疾病管制与预防中心的数据，大约 2,010 万名 20 岁及以上的成年人患有冠状动脉疾病，这一比例在美国约为 7.2%。根据国家生物技术资讯中心的数据，2023 年，骨质疏鬆症是全球和热带国家最常见的代谢性骨病。停经后女性骨质疏鬆症盛行率为30%至50%，50岁以上男性骨质疏鬆症盛行率高达20%。此外，据世界卫生组织称，到2023 年，癌症、慢性阻塞性肺病、哮喘、糖尿病和心血管疾病等疾病影响低收入和中等收入国家的人们，这些国家的非传染性疾病死亡人数占全球非传染性疾病死亡人数的四分之三以上（31.4万）发生，四舍五入到80％。大约 1700 万人在 70 岁前死于非传染性疾病。

由于慢性病和传染病的发生率不断上升，主要参与者纷纷推出医疗用品和设备，以提供更有效的诊断和治疗。例如，2023 年 8 月，GE HealthCare 宣布推出用于心房颤动 (AFib) 的 CardioVisio，这是一种数位工具，旨在帮助临床医生可视化来自多个资料来源的与疾病进展相关的纵向资料，同时推动以证据为基础的临床决策支持最新的 AFib 指南。因此，慢性病和传染病的流行以及产品的推出推动了市场的发展。

医疗设备成本高

医疗用品和设备的成本不断增加阻碍了市场。医疗设备的成本从 2,000 美元到 100,000 美元不等。牙科设备的平均价格约为 7,501 美元，眼科设备的平均价格约为 8,012 美元。价格也根据所使用的技术和品牌价值而有所不同。高端医疗设备的成本随着品牌价值的增加而增加。人工智慧、机器学习、机器人等先进功能的整合将成本提高到更高的水平。维护成本也随之上涨，这对大多数买家来说都是一个负担。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

• 影响因素
  • 司机
    • 慢性病和传染病的盛行率不断增加
  • 限制
    • 医疗设备成本高昂
  • 机会
  • 影响分析

第 5 章：产业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 监管分析
• 报销分析
• 专利分析
• SWOT分析
• DMI 意见

第 6 章：按类型

• 心血管
• 牙科
• 一次性设备和用品
• 一般设备和用品
• 生命科学工具与服务
• 其他的

第 7 章：按申请

• 泌尿科
• 伤口护理
• 放射科
• 感觉缺失
• 消毒
• 其他应用

第 8 章：最终用户

• 医院
• 诊所
• 辅助生活中心及疗养院
• 门诊手术中心
• 其他的

第 9 章：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 中东和非洲

第 10 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 11 章：公司简介

• Medtronic Inc.
• 公司概况
• 产品组合和描述
• 财务概览
• 主要进展
• Becton Dickinson & Company
• Baxter International Inc.
• Align Technology Inc.
• IDEXX Laboratories Inc.
• Henry Schein Inc.
• Cooper Companies Inc.
• Bio Rad Laboratories Inc.
• Hill Rom Hldg Inc.
• ICU Medical Inc.

第 12 章：附录

The global Medical Supplies and Equipments Market reached US$ 143.1 billion in 2023 and is expected to reach US$ 188.58 billion by 2031, growing at a CAGR of 3.6% during the forecast period 2024-2031.

Medical supplies and equipment are used in hospitals and clinics for medical purposes such as surgeries. These supplies allow health care professionals to assess a patient's medical needs. The medical supplies and equipment include storage and transport, durable medical equipment, and diagnostic and electronic medical equipment.

The Medical Supplies and Equipments Market is driven by the factors such as the increasing prevalence of chronic diseases, increasing demand for novel treatment options, increasing awareness, growing patient demand for better treatment, and advancements in treatment options. The North America region is expected to hold the largest market share owing to the strong presence of majors in the region.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic and infectious diseases

The increasing prevalence of chronic diseases is expected to be a significant factor in the growth of the global Medical Supplies and Equipments Market. The market is anticipated to be driven by the growing number of patients with chronic diseases like cancer, diabetes, and cardiovascular conditions. For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults age 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur that rounds up to 80%. Approximately 17 million people die from an NCD before age 70.

As a result of increasing prevalence of chronic and infectious diseases, the major players have launched medical supplies and equipments to provide more efficient diagnosis and treatments. For instance, in August 2023, GE HealthCare has announced the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool designed to help clinicians visualize longitudinal data relevant to disease progression from multiple data sources while driving evidence-based clinical decision support guided by the most recent AFib guidelines. So, the market is driven as a result of increasing prevalence of chronic and infectious diseases and launch of products.

High costs of medical equipment

The increasing cost of medical supplies and equipment hinders the market. The cost of medical equipment goes from $2,000 to $100,000 USD. The average price of dental equipment ranges around $7,501, ophthalmology ranges around $8,012. The price also varies according to the technology used and brand value. Highend medical equipment costs where in the brand value adds up. Integration of advanced features like artificial intelligence, machine learning, robotics, etc brings up the cost to a higher level. The maintenance costs also shoot up which can be a burden for most of the buyers.

Segment Analysis

The global Medical Supplies and Equipments Market is segmented based on product type, technology, distribution channel and region.

Orthopedic implants and prosthetics segment is expected to dominate the global Medical Supplies and Equipments Market share

The Orthopedic Implants and Prosthetics segment is expected to dominate the global medical supplies and equipment's market. Orthopedic Implants are designed to replace a damaged bone or cartilage which mostly occurs by accidents and injuries. Most of the implants and prosthetics are used to cover up the damages caused due to burns and injuries that destroy bones and other cartilage at the target site. Ageing also causes destruction of bone density which gives rise to diseases like osteoporosis. Bone-related diseases lead to severe pain which sometimes requires replacement surgery that makes use of orthopedic implants.

Orthopedic Implants and Prosthetics is expected to hold the largest share in the segment due to the increasing product launches and advancements by key companies like Johnson & Johnson and Smith+Nephew etc. For instance, in July 2023, the Orthopaedic Implant Company (OIC) has announced the launch of its unique Threaded Metacarpal Nail System. This innovative approach to metacarpal fixation represents a huge step forward in hand fracture care, offering orthopedic surgeons a superior solution that combines efficiency, stability, and convenience of use. The OIC Threaded Metacarpal Nail System has a low insertion torque and a minimally compressive design, ensuring maximum stability for a variety of fracture patterns. The completely threaded construction and tapered head diameter enable robust fixation, allowing for early mobilization of patients. So, the increased accidents and injuries and new launches that use advanced technology make the segment the most dominating.

Geographical Analysis

North America is expected to hold a significant position in the global Medical Supplies and Equipments Market share

North America is expected to hold a significant portion of the global Medical Supplies and Equipments Market. The North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America, particularly the United States, has a well-developed healthcare infrastructure with advanced medical facilities, research institutions, and specialized dermatology centers. This infrastructure supports the diagnosis, treatment, facilitating the growth of the market. The availability of specialized healthcare professionals further enhances the quality of care provided to patients. The region is at the forefront of technological advancements in healthcare. North America is known for its strong emphasis on research and development, leading to the introduction of innovative treatment options and diagnostic tools for chronic diseases like cancer.

Advancements in medical devices and integration with AI and machine learning keep up the demand for medical devices in this region. For instance, in June 2023, A-dec launched the First Digitally Connected Dental Chair and Delivery System. A-dec 500 Pro and A-dec 300 Pro delivery systems available for North American markets The United States boasts advanced healthcare infrastructure, including state-of-the-art hospitals, research institutions, and medical facilities. This infrastructure facilitates the adoption of the latest technologies and advancements in medical devices.

Asia Pacific is growing at the fastest pace in the global medical supplies and equipment's market

Asia Pacific is experiencing the fastest growth in global medical supplies and equipment's market owing to the increasing incidence of chronic diseases and technological advancements in the region. For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively. The growing burden of noncommunicable diseases (NCDs) has prompted healthcare systems to seek innovative approaches to care delivery, leading to increased demand for medical supplies and equipment tailored for chronic disease management

Competitive Landscape

The major global players in the global Medical Supplies and Equipments Market include Medtronic Inc., Becton Dickinson & Company, Baxter International Inc., Align Technology Inc., IDEXX Laboratories Inc., Henry Schein Inc., Cooper Companies Inc., Bio Rad Laboratories Inc., Hill Rom Hldg Inc., ICU Medical Inc. among others.

Emerging Players

Genomtec, QuantiLight, and GeneSys Bio among others

Key Developments

• In February 2023, CurvaFix, Inc. launched a smaller-diameter, 7.5mm CurvaFix IM Implant, designed to simplify surgery and provide strong, stable fixation in small-boned patients.
• In October 2023, DePuy Synthes launched VELYS Robotic-Assisted Solution on the European Market. It is designed to facilitate procedural efficiency, predictability, and standardization.
• In August 2023, Smith+Nephew launched the OR3O dual mobility system for hip arthroplasty in India.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Medical Supplies and Equipments Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Chronic and Infectious Diseases
  • 4.1.2. Restraints
    • 4.1.2.1. High Costs of Medical Equipment
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Cardiovascular*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Dental
• 6.4. Disposable equipment and supplies
• 6.5. General equipment and supplies
• 6.6. Life science tools and services
• 6.7. Others

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Urology*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Wound Care
• 7.4. Radiology
• 7.5. Panesthesia
• 7.6. Sterilization
• 7.7. Other Applications

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospital*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Clinic
• 8.4. Assisted Living Centers & Nursing Homes
• 8.5. Ambulatory Surgery Centers
• 8.6. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Becton Dickinson & Company
• 11.3. Baxter International Inc.
• 11.4. Align Technology Inc.
• 11.5. IDEXX Laboratories Inc.
• 11.6. Henry Schein Inc.
• 11.7. Cooper Companies Inc.
• 11.8. Bio Rad Laboratories Inc.
• 11.9. Hill Rom Hldg Inc.
• 11.10. ICU Medical Inc.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us